December 22, 2017
The Ministry of Health, Labor and Welfare (MHLW) on December 21 granted orphan drug designation for Kyowa Hakko Kirin’s mogamulizumab for the treatment of HTLV-1-associated myelopathy. HTLV-1-associated myelopathy affects an estimated 3,600 people in Japan. The MHLW informed prefectural health...read more